MoonLake Immunotherapeutics (MLTX) Common Equity (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) reported Common Equity of $428.2 million for Q2 2026, up 19.6% from $357.94 million a year earlier and up 68.6% from the prior quarter.
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, MoonLake Immunotherapeutics posted Common Equity of $304.48 million, down 32.8% from FY2024.
- By year, Common Equity came in at $453.39 million in FY2024 (-11.7%), $513.49 million in FY2023 (+646.7%), $68.77 million in FY2022 and -$11.65 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q4 2024.
- Year over year, Common Equity gained in two of the last eight quarters, with an average decline of 20.1%.
- The high point for year-over-year Common Equity in five years was Q1 2024 (growth of 834.5%); the low point was Q3 2025 (a decline of 41.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $254.02 million (Q1 2026), $304.48 million (Q4 2025) and $291.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | MoonLake Immunotherapeutics | 983.83 Mn | -685.56 Mn | - | 428.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 428.20 Mn |
| Mar 31, 2026 | 254.02 Mn |
| Dec 31, 2025 | 304.48 Mn |
| Sep 30, 2025 | 291.19 Mn |
| Jun 30, 2025 | 357.94 Mn |
| Mar 31, 2025 | 412.58 Mn |
| Dec 31, 2024 | 453.39 Mn |
| Sep 30, 2024 | 495.50 Mn |
| Jun 30, 2024 | 530.03 Mn |
| Mar 31, 2024 | 552.39 Mn |
| Dec 31, 2023 | 513.49 Mn |
| Sep 30, 2023 | 489.64 Mn |
| Jun 30, 2023 | 499.11 Mn |
| Mar 31, 2023 | 59.11 Mn |
| Dec 31, 2022 | 68.77 Mn |
| Sep 30, 2022 | 82.57 Mn |
| Jun 30, 2022 | 94.56 Mn |
| Mar 31, 2022 | -25.27 Mn |
| Dec 31, 2021 | -11.65 Mn |
| Sep 30, 2021 | -3.10 Mn |
API Access
MoonLake Immunotherapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MLTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MLTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MLTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();